ADMS - Adamas Pharmaceuticals Inc. (ADMS) CEO Neil McFarlane on Q1 2020 Results - Earnings Call Transcript
Adamas Pharmaceuticals, Inc. (ADMS)
Q1 2020 Earnings Conference Call
May 07, 2020 05:00 PM ET
Company Participants
Peter Vozzo - Investor Relations
Neil McFarlane - Chief Executive Officer
Vijay Shreedhar - Chief Commercial Officer
Chris Prentiss - Chief Financial Officer.
Conference Call Participants
Josh Schimmer - Evercore
Marc Goodman - Leerink
Ken Cacciatore - Cowen
Jason Butler - JMP Securities
Tim Lugo - William Blair
Presentation
Operator
Welcome to the Adamas Pharmaceuticals First Quarter 2020 Financial Results Corporate Update Conference Call. At this time, all participants' lines are in a listen-only mode. After the speakers'